These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 9559229
1. Differential diagnosis of hepatic tumors with delayed enhancement at gadolinium-enhanced MRI: a pictorial essay. Awaya H, Ito K, Honjo K, Fujita T, Matsumoto T, Matsunaga N. Clin Imaging; 1998; 22(3):180-7. PubMed ID: 9559229 [Abstract] [Full Text] [Related]
2. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful? Chung JJ, Kim MJ, Kim KW. J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954 [Abstract] [Full Text] [Related]
3. Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient. Hammerstingl R, Zangos S, Schwarz W, Rosen T, Bechstein WO, Balzer T, Vogl TJ. Acad Radiol; 2002 May; 9 Suppl 1():S119-20. PubMed ID: 12019845 [No Abstract] [Full Text] [Related]
4. Liver-specific agents for contrast-enhanced MRI: role in oncological imaging. Thian YL, Riddell AM, Koh DM. Cancer Imaging; 2013 Dec 30; 13(4):567-79. PubMed ID: 24434892 [Abstract] [Full Text] [Related]
5. MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment. Grazioli L, Kirchin M, Pirovano G, Spinazzi A. J Comput Assist Tomogr; 1999 Nov 30; 23 Suppl 1():S61-4. PubMed ID: 10608399 [Abstract] [Full Text] [Related]
6. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. Chiu FY, Jao JC, Chen CY, Liu GC, Jaw TS, Chiou YY, Hsu FO, Hsu JS. J Comput Assist Tomogr; 2005 Nov 30; 29(2):176-80. PubMed ID: 15772533 [Abstract] [Full Text] [Related]
7. The ins and outs of liver imaging. O'Neill EK, Cogley JR, Miller FH. Clin Liver Dis; 2015 Feb 30; 19(1):99-121. PubMed ID: 25454299 [Abstract] [Full Text] [Related]
8. Diagnostic imaging of hepatic lesions in adults. Lamba R, Fananapazir G, Corwin MT, Khatri VP. Surg Oncol Clin N Am; 2014 Oct 30; 23(4):789-820. PubMed ID: 25246050 [Abstract] [Full Text] [Related]
9. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session]. Heilmaier C, Sutter R, Lutz AM, Seifert B, Willmann JK. Rofo; 2008 May 30; 180(5):440-8. PubMed ID: 18438745 [Abstract] [Full Text] [Related]
10. Characterization of focal hepatic lesions with SPIO-enhanced MRI. Zheng WW, Zhou KR, Chen ZW, Shen JZ, Chen CZ, Zhang SJ. World J Gastroenterol; 2002 Feb 30; 8(1):82-6. PubMed ID: 11833077 [Abstract] [Full Text] [Related]
11. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma. Leyendecker JR, Gakhal M, Elsayes KM, McDermott R, Narra VR, Brown JJ. J Comput Assist Tomogr; 2008 Feb 30; 32(2):178-84. PubMed ID: 18379298 [Abstract] [Full Text] [Related]
12. ACG clinical guideline: the diagnosis and management of focal liver lesions. Marrero JA, Ahn J, Rajender Reddy K, Americal College of Gastroenterology. Am J Gastroenterol; 2014 Sep 30; 109(9):1328-47; quiz 1348. PubMed ID: 25135008 [Abstract] [Full Text] [Related]
13. Evaluation of focal hepatic lesions with ultrasound contrast agents. Sutherland T, Temple F, Lee WK, Hennessy O. J Clin Ultrasound; 2011 Sep 30; 39(7):399-407. PubMed ID: 21674510 [Abstract] [Full Text] [Related]
14. MRI of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (≤3 cm) with cirrhosis and chronic viral hepatitis: a comparative study. Sheng RF, Zeng MS, Rao SX, Ji Y, Chen LL. Clin Imaging; 2014 Sep 30; 38(3):265-72. PubMed ID: 24559750 [Abstract] [Full Text] [Related]
15. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Park HJ, Kim YK, Park MJ, Lee WJ. Abdom Imaging; 2013 Aug 30; 38(4):793-801. PubMed ID: 22829097 [Abstract] [Full Text] [Related]
16. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images. Karabacakoğlu A, Adigüzel Y, Karaköse S, Kayaçetin E, Haykir R. Turk J Gastroenterol; 2006 Sep 30; 17(3):164-71. PubMed ID: 16941248 [Abstract] [Full Text] [Related]
17. Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI. Kim YK, Han YM, Kim CS. Eur J Radiol; 2009 Apr 30; 70(1):94-100. PubMed ID: 18316169 [Abstract] [Full Text] [Related]
18. Hepatic Sclerosed Hemangioma: a case report and review of the literature. Miyamoto S, Oshita A, Daimaru Y, Sasaki M, Ohdan H, Nakamitsu A. BMC Surg; 2015 Apr 17; 15():45. PubMed ID: 25927893 [Abstract] [Full Text] [Related]
19. [A case of sclerosed hemangioma mimicking intrahepatic cholangiocarcinoma]. Park SM, Shin SM, Seo HE, Kim SH, Kim HS, Park JH, Kim JH, Sohn KR. Korean J Gastroenterol; 2009 Dec 17; 54(6):399-403. PubMed ID: 20026896 [Abstract] [Full Text] [Related]
20. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA]. Olivetti L, Grazioli L, Maroldi R, Matricardi L, Milanesio L. Radiol Med; 1992 Apr 17; 83(4):353-60. PubMed ID: 1318558 [Abstract] [Full Text] [Related] Page: [Next] [New Search]